citalopram has been researched along with Basal Ganglia Diseases in 7 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Baclofen and oxazepam were prescribed secondary to right-sided hemiparesis contractures." | 1.34 | Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities. ( Brahm, NC; Brown, RC; McElwain, DL, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, MY | 1 |
| Etminan, M | 1 |
| Procyshyn, RM | 1 |
| Kim, DD | 1 |
| Samii, A | 1 |
| Kezouh, A | 1 |
| Carleton, BC | 1 |
| Nimber, JS | 1 |
| Aggarwal, A | 1 |
| Muthusami, S | 1 |
| Basu, S | 1 |
| Kumar, A | 1 |
| Dash, A | 1 |
| Thwaites, JH | 1 |
| Hutchinson, C | 1 |
| Collins, C | 1 |
| Brahm, NC | 1 |
| McElwain, DL | 1 |
| Brown, RC | 1 |
| Kwon, P | 1 |
| Lefkowitz, W | 1 |
| Pollock, BG | 1 |
| Mulsant, BH | 1 |
1 review available for citalopram and Basal Ganglia Diseases
| Article | Year |
|---|---|
Behavioral disturbances of dementia.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Behavioral S | 1998 |
6 other studies available for citalopram and Basal Ganglia Diseases
| Article | Year |
|---|---|
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxeti | 2018 |
Acute extrapyramidal syndrome induced by escitalopram: a case report.
Topics: Acute Disease; Adult; Basal Ganglia Diseases; Citalopram; Depressive Disorder; Female; Humans; Selec | 2014 |
Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram.
Topics: Acute Disease; Alprazolam; Anti-Anxiety Agents; Anxiety; Basal Ganglia Diseases; Chest Pain; Child; | 2009 |
Neurotoxic reaction to citalopram.
Topics: Aged; Basal Ganglia Diseases; Citalopram; Depressive Disorder; Dystonia; Female; Humans; Parkinson D | 2006 |
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; | 2007 |
Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
Topics: Adult; Anti-Anxiety Agents; Basal Ganglia Diseases; Citalopram; Female; Humans; Infant, Newborn; Lor | 2008 |